Related Experiment Video
Updated: Aug 8, 2026
09:27
Protein Crystallization for X-ray Crystallography
Published on: January 16, 2011
Crystallization to obtain protein-ligand complexes for structure-aided drug design
1Department of Exploratory Medicinal Sciences, Pfizer Global Research and Development, Pfizer Inc., Groton, CT 06340, USA. dennis.e.danley@pfizer.com
Summary
Structure-aided drug design (SADD) relies on X-ray crystallography for target-ligand complexes. This article discusses challenges and strategies for successfully obtaining these crucial co-structures in drug discovery.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Structure-aided drug design (SADD) utilizes X-ray crystallography to determine three-dimensional protein-ligand complex structures.
- Obtaining these co-structures is essential for iterative molecular design in drug discovery.
- Cocrystallization or soaking methods are frequently employed to achieve these complexes.
Purpose of the Study:
- To identify and discuss potential factors contributing to the unsuccessful formation of protein-inhibitor co-crystals.
- To provide considerations for experimental design aimed at improving the success rate of obtaining iterative co-structures.
Main Methods:
- Review and discussion of common challenges encountered during the crystallization of protein-ligand complexes.
- Analysis of factors influencing the success of cocrystallization and soaking techniques.
Main Results:
- Identified numerous potential reasons for the failure to obtain desired protein-ligand co-structures.
- Outlined key considerations for optimizing experimental strategies.
Conclusions:
- Successful SADD is contingent on the ability to form protein-ligand co-crystals.
- Addressing specific experimental factors can enhance the likelihood of obtaining these critical structures for drug design.
